Post-earnings recap
Reported
Tue, Oct 24, 2023
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Quest Diagnostics reported an EPS of $2.22, slightly beating expectations. The stock reacted positively, rising by 1.75%. However, there was no revenue data provided, and no guidance updates were given, leaving some uncertainty about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.22 | N/A | +1.28% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.